1 completed, 1 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Unknown 1 |
Follow Anticoagulant: new trials by email Literature Review of Anticoagulant trials Research Report on Anticoagulant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Low Molecular Weight Heparins Dalteparin Prefilled Syringe, Tinzaparin profiled syringe - Anticoagulant, Venous Thromboembolism | Phase 4 | Unknown | Herlev Hospital | 65000 | 2023-03-23 | 2023-08-31 |
| Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer Study 12-month Edoxaban, 3-month Edoxaban - Venous Thrombosis, Neoplasms | Phase 4 | Completed | Takeshi Morimoto | 605 | 2019-05-27 | 2023-10-04 |
Neoplasms (1) · Venous Thromboembolism (1) · Venous Thrombosis (1)
Cardiovascular Diseases (2) · Embolism and Thrombosis (2) · Vascular Diseases (2) · Thromboembolism (1) · Thrombosis (1)
edoxaban (1)
Herlev Hospital (1) · Takeshi Morimoto (1)
Denmark (1) · Japan (1)